These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8799234)

  • 1. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR; Brunken RC; Saha GB; Underwood DA; Marwick TH; Chen EQ; King JL; Khandekar S
    J Nucl Cardiol; 1996; 3(2):96-104. PubMed ID: 8799234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
    Huitink JM; Visser FC; Bax JJ; van Lingen A; Visser CA
    Int J Cardiol; 1996 Dec; 57(3):271-81. PubMed ID: 9024916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT; MacIntyre WJ; Saha GB; Cook SA; Neumann DR; Chen EQ; Underwood DA; Kaczur T
    Radiology; 1995 Jan; 194(1):151-5. PubMed ID: 7997543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ischemic and hibernating myocardium: feasibility of post-exercise F-18 deoxyglucose positron emission tomography.
    Marwick TH; MacIntyre WJ; Salcedo EE; Go RT; Saha G; Beachler A
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):100-6. PubMed ID: 2009557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
    Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS; deKemp R; Scheffel A; Nahmias C; Garnett ES; Coates G; Johansen HL; Fallen E
    J Am Coll Cardiol; 1997 Mar; 29(3):537-43. PubMed ID: 9060890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
    Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
    J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Am Coll Cardiol; 1996 Oct; 28(4):948-58. PubMed ID: 8837573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
    Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
    J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
    Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
    J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.